今日熱門話題

th/ca/Epstein-Barr virus Multiple sclerosis/Atara Biotherapeutics Presents New Magnetization Transfer Ratio Imaging Data and Two-Year Clinical Data from the Open Label Extension of ATA188 for Progressive Multiple Sclerosis at ECTRIMS 2021

|

You are leaving and open the following URL" of about "hk" news

www.businesswire.com/news/home/20211013005398/en/Atara-Biotherapeutics-Presents-New-Magnetization-Transfer-Ratio-Imaging-Data-and-Two-Year-Clinical-Data-from-the-Open-Label-Extension-of-ATA188-for-Progressive-Multiple-Sclerosis-at-ECTRIMS-2021


Continue Opne >

hk: th/ca/Epstein-Barr virus Multiple sclerosis/Atara Biotherapeutics Presents New Magnetization Transfer Ratio Imaging Data and Two-Year Clinical Data from the Open Label Extension of ATA188 for Progressive Multiple Sclerosis at ECTRIMS 2021


More hk news:


About hk

from

hk, th/ca/Epstein-Barr virus Multiple sclerosis/Atara Biotherapeutics Presents New Magnetization Transfer Ratio Imaging Data and Two-Year Clinical Data from the Open Label Extension of ATA188 for Progressive Multiple Sclerosis at ECTRIMS 2021 2022 hk

th/ca/Epstein-Barr virus Multiple sclerosis/Atara Biotherapeutics Presents New Magnetization Transfer Ratio Imaging Data and Two-Year Clinical Data from the Open Label Extension of ATA188 for Progressive Multiple Sclerosis at ECTRIMS 2021

Choose Your Country or Region


Back to Top



Copyright © 2020-2021 loohk.com. All Rights Reserved.